Hematologic Cancers

Hematologic cancer is the mostly spread and most common disorder among other Blood disorders and is a very important aspect of Blood disorder research. Blood malignancies affect the performance and formation of your blood cells. Cancerous cells restrict your blood from performing its important/regular functions, like prohibiting from serious bleeding or fighting with foreign body/infections agents. A chief part of blood-based investigation is going on in this field. Leukaemia mainly affects the white blood cells (WBCs) and are closely linked to the lymphomas and some of them are deeply related to the adult T cells leukaemia, these disorders comes under the lymph proliferative disorders. The cancer which originates from WBCs (white blood cells) is known as lymphoma and this type of disorder is mainly seen in Hodgkin lymphoma these diseases can be treated with hematopoietic stem cell transplantation, radiation therapy and chemotherapy. The bone marrow in which a large number of white blood cells develop that leads to multiple myeloma

  • Hodgkin and non-Hodgkin lymphoma
  • Myelogenous leukemia
  • Acute lymphocytic
  • Chronic lymphocytic
  • Multiple Myeloma

Related Conference of Hematologic Cancers


November 25-26, 2019

17th World Hematology & Blood Disorders Conference


HOLIDAY INN PARIS - PORTE DE CLICHY 2 Rue du 8 Mai 1945, 92110 Clichy, France

March 16-17, 2020

18th World Hematology Congress

London, UK
November 23-24, 2020

Annual Hematology Congress

Dubai, UAE
September 17-18, 2020

World Summit on Hematology and Cell Therapy

Osaka, Japan

Hematologic Cancers Conference Speakers

Recommended Sessions

Related Journals

Are you interested in